%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Debbie M. Roeleveld, Renoud J. Marijnissen, Birgitte Walgreen, Monique M. Helsen, Liduine van den Bersselaar, Fons A. van de Loo, Peter L. van Lent, Peter M. van der Kraan, Wim B. van den Berg, Marije I. Koenders
Higher efficacy of anti-IL-6/IL-21 combination therapy compared to monotherapy in the induction phase of Th17-driven experimental arthritis
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 15 0 R/Annots 16 0 R/Contents 17 0 R/TrimBox[0 0 612 792]>>
endobj
16 0 obj
[18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R]
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171757.ref002)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171757.ref005)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171757.ref005)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171757.ref007)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171757.ref008)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171757.ref014)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171757.ref015)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171757.ref016)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171757.ref017)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171757.ref018)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171757.ref019)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171757.ref021)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171757.ref020)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171757.ref022)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpone.0171757.ref023)>>
endobj
17 0 obj
[33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R]
endobj
33 0 obj
<>stream
q
0.83 0.64 0.02 0 k
226.4882 693.2976 m
231.2504 693.2976 l
h
f*
236.4094 693.2976 m
241.1717 693.2976 l
h
f*
364.8756 680.315 m
369.6378 680.315 l
h
f*
374.8535 680.315 m
379.5591 680.315 l
h
f*
234.085 641.3102 m
238.8472 641.3102 l
h
f*
244.0063 641.3102 m
253.5307 641.3102 l
h
f*
529.7953 628.3276 m
539.3197 628.3276 l
h
f*
541.5874 628.3276 m
551.0551 628.3276 l
h
f*
521.6315 563.3008 m
531.1559 563.3008 l
h
f*
533.4236 563.3008 m
542.948 563.3008 l
h
f*
373.4929 537.3354 m
383.0173 537.3354 l
h
f*
388.1764 537.3354 m
397.7008 537.3354 l
h
f*
457.115 511.3134 m
466.6394 511.3134 l
h
f*
468.9071 511.3134 m
478.3748 511.3134 l
h
f*
500.3717 268.1008 m
509.8961 268.1008 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 200.0125 707.4141 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(approximately)Tj
5.9753 0 Td
(30%)Tj
1.9276 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(patients)Tj
3.3676 0 Td
(still)Tj
1.6384 0 Td
(fail)Tj
1.457 0 Td
(to)Tj
1.0261 0 Td
(respond)Tj
3.4753 0 Td
(adequately)Tj
4.4957 0 Td
(to)Tj
1.0261 0 Td
(currently)Tj
3.8835 0 Td
(available)Tj
3.668 0 Td
(treat-)Tj
-34.4237 -1.3039 Td
(ment)Tj
2.3073 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
2.5966 0 Td
(Interestingly,)Tj
5.4935 0 Td
(anti-TNF)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
4.558 0 Td
(non-responders)Tj
6.5877 0 Td
(were)Tj
2.126 0 Td
(shown)Tj
2.846 0 Td
(to)Tj
1.0261 0 Td
(have)Tj
2.0579 0 Td
(increased)Tj
4.0025 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
-35.977 -1.2982 Td
(T)Tj
0.8277 0 Td
(helper)Tj
2.7325 0 Td
(\(Th\)17)Tj
2.9877 0 Td
(cells)Tj
1.9219 0 Td
(in)Tj
1.0375 0 Td
(their)Tj
2.109 0 Td
(circulation)Tj
4.5297 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(],)Tj
2.5965 0 Td
(suggesting)Tj
4.405 0 Td
(Th17)Tj
2.3074 0 Td
(cells)Tj
1.9219 0 Td
(and)Tj
1.7291 0 Td
(Th17-derived)Tj
5.6579 0 Td
(cyto-)Tj
-34.7638 -1.2983 Td
(kines)Tj
2.313 0 Td
(might)Tj
2.6022 0 Td
(be)Tj
1.1509 0 Td
(interesting)Tj
4.49 0 Td
(alternative)Tj
4.422 0 Td
(therapeutic)Tj
4.7282 0 Td
(targets)Tj
2.8743 0 Td
(in)Tj
1.0375 0 Td
(RA.)Tj
1.7461 0 Td
(Th17)Tj
2.3131 0 Td
(cells)Tj
1.9218 0 Td
(produce)Tj
3.515 0 Td
(various)Tj
-33.1141 -1.2983 Td
(pro-inflammatory)Tj
7.455 0 Td
(cytokines)Tj
3.9968 0 Td
(like)Tj
1.6555 0 Td
(IL-17,)Tj
2.6248 0 Td
(IL-21,)Tj
2.6249 0 Td
(and)Tj
1.7291 0 Td
(IL-22,)Tj
2.6249 0 Td
(that)Tj
1.7801 0 Td
(have)Tj
2.058 0 Td
(been)Tj
2.1259 0 Td
(linked)Tj
2.727 0 Td
(to)Tj
1.0261 0 Td
(RA)Tj
1.525 0 Td
(patho-)Tj
-33.9531 -1.3039 Td
(genesis)Tj
3.067 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(].)Tj
3.0728 0 Td
(Arthritis)Tj
3.6623 0 Td
(animal)Tj
2.9707 0 Td
(models)Tj
3.1067 0 Td
(have)Tj
2.058 0 Td
(further)Tj
3.0274 0 Td
(elucidated)Tj
4.3199 0 Td
(the)Tj
1.4684 0 Td
(role)Tj
1.7688 0 Td
(of)Tj
1.0148 0 Td
(these)Tj
2.2563 0 Td
(Th17)Tj
2.3074 0 Td
(cyto-)Tj
-34.1005 -1.2982 Td
(kines)Tj
2.313 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(processes)Tj
3.9685 0 Td
(of)Tj
1.0148 0 Td
(joint)Tj
2.0976 0 Td
(inflammation)Tj
5.6976 0 Td
(and)Tj
1.7348 0 Td
(destruction)Tj
4.7735 0 Td
(of)Tj
1.0148 0 Td
(cartilage)Tj
3.583 0 Td
(and)Tj
1.7291 0 Td
(bone)Tj
2.2054 0 Td
([)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(].)Tj
-32.6379 -1.2983 Td
(These)Tj
2.5681 0 Td
(findings)Tj
3.4923 0 Td
(indicate)Tj
3.4072 0 Td
(that)Tj
1.7802 0 Td
(Th17)Tj
2.3073 0 Td
(cells)Tj
1.9219 0 Td
(and)Tj
1.7291 0 Td
(their)Tj
2.109 0 Td
(cytokines)Tj
4.0025 0 Td
(are)Tj
1.4457 0 Td
(important)Tj
4.2802 0 Td
(contributors)Tj
5.2101 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
-35.2797 -1.3039 Td
(pathogenesis)Tj
5.3517 0 Td
(of)Tj
1.0148 0 Td
(chronic)Tj
3.2882 0 Td
(and)Tj
1.7291 0 Td
(destructive)Tj
4.5978 0 Td
(joint)Tj
2.0976 0 Td
(inflammation)Tj
5.6976 0 Td
(during)Tj
2.931 0 Td
(RA.)Tj
-25.5116 -1.2983 Td
(Differentiation)Tj
6.1908 0 Td
(of)Tj
1.0148 0 Td
(Th17)Tj
2.3074 0 Td
(cells)Tj
1.9219 0 Td
(from)Tj
2.2053 0 Td
(na)Tj
/F12 1 Tf
[()]TJ
/F7 1 Tf
(ve)Tj
2.3357 0 Td
(CD4+)Tj
2.6759 0 Td
(T)Tj
0.8334 0 Td
(cells)Tj
1.9219 0 Td
(is)Tj
0.8447 0 Td
(mediated)Tj
3.9401 0 Td
(by)Tj
1.1849 0 Td
(the)Tj
1.4683 0 Td
(enhanced)Tj
4.0762 0 Td
(expres-)Tj
-34.1175 -1.2983 Td
(sion)Tj
1.9048 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(transcription)Tj
5.4311 0 Td
(factor)Tj
2.5455 0 Td
(RAR-related)Tj
5.2214 0 Td
(orphan)Tj
3.1237 0 Td
(nuclear)Tj
3.1975 0 Td
(receptor)Tj
/F11 1 Tf
3.5546 0 Td
(\r)Tj
/F7 1 Tf
(t)Tj
0.9751 0 Td
(\(ROR)Tj
/F11 1 Tf
(\r)Tj
/F7 1 Tf
(t\),)Tj
3.8665 0 Td
(originally)Tj
-32.3034 -1.3039 Td
(thought)Tj
3.3732 0 Td
(to)Tj
1.0204 0 Td
(be)Tj
1.1509 0 Td
(induced)Tj
3.4696 0 Td
(exclusively)Tj
4.5127 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.4683 0 Td
(combined)Tj
4.2463 0 Td
(signaling)Tj
3.8211 0 Td
(of)Tj
1.0148 0 Td
(TGF-)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
2.914 0 Td
(and)Tj
1.7291 0 Td
(IL-6)Tj
1.9219 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
3.2541 0 Td
(How-)Tj
-35.0756 -1.2982 Td
(ever,)Tj
2.1146 0 Td
(later)Tj
1.9956 0 Td
(it)Tj
0.788 0 Td
(was)Tj
1.6951 0 Td
(shown)Tj
2.8516 0 Td
(that)Tj
1.7745 0 Td
(signaling)Tj
3.8268 0 Td
(of)Tj
1.0148 0 Td
(TGF-)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
2.9083 0 Td
(combined)Tj
4.2463 0 Td
(with)Tj
1.9955 0 Td
(the)Tj
1.4684 0 Td
(autocrine)Tj
4.0251 0 Td
(signaling)Tj
3.8211 0 Td
(of)Tj
1.0148 0 Td
(IL-)Tj
-35.5405 -1.2983 Td
(21)Tj
1.1678 0 Td
(could)Tj
2.4548 0 Td
(drive)Tj
2.262 0 Td
(Th17)Tj
2.3131 0 Td
(differentiation)Tj
5.9754 0 Td
(as)Tj
1.0148 0 Td
(well)Tj
1.8198 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(21)Tj
0 g
(].)Tj
3.549 0 Td
(Both)Tj
2.1316 0 Td
(IL-6)Tj
1.9219 0 Td
(and)Tj
1.7348 0 Td
(IL-21)Tj
2.3981 0 Td
(induce)Tj
2.9367 0 Td
(upregulation)Tj
-31.6798 -1.3039 Td
(of)Tj
1.0147 0 Td
(the)Tj
1.4684 0 Td
(IL-23)Tj
2.3981 0 Td
(receptor)Tj
3.5603 0 Td
(\(IL-23R\))Tj
3.6963 0 Td
(in)Tj
1.0375 0 Td
(na)Tj
/F12 1 Tf
[()]TJ
/F7 1 Tf
(ve)Tj
2.3357 0 Td
(CD4+)Tj
2.6759 0 Td
(T)Tj
0.8334 0 Td
(cells,)Tj
2.143 0 Td
(making)Tj
3.2541 0 Td
(those)Tj
2.3358 0 Td
(cells)Tj
1.9218 0 Td
(responsive)Tj
4.4561 0 Td
(to)Tj
1.0261 0 Td
(IL-23.)Tj
-34.1572 -1.2983 Td
(IL-23)Tj
2.398 0 Td
(can)Tj
1.6271 0 Td
(subsequently)Tj
5.4085 0 Td
(amplify)Tj
3.2428 0 Td
(the)Tj
1.4683 0 Td
(differentiation)Tj
5.9811 0 Td
(of)Tj
1.0148 0 Td
(Th17)Tj
2.3074 0 Td
(cells)Tj
1.9219 0 Td
([)Tj
0.83 0.64 0.02 0 k
(20)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(22)Tj
0 g
(].)Tj
3.2541 0 Td
(When)Tj
2.6872 0 Td
(either)Tj
2.5285 0 Td
(the)Tj
1.4684 0 Td
(IL-6)Tj
-35.3081 -1.2982 Td
(or)Tj
1.0941 0 Td
(IL-21)Tj
2.4038 0 Td
(signaling)Tj
3.8211 0 Td
(pathway)Tj
3.5716 0 Td
(is)Tj
0.8447 0 Td
(absent,)Tj
3.0217 0 Td
(differentiation)Tj
5.9754 0 Td
(of)Tj
1.0148 0 Td
(na)Tj
/F12 1 Tf
[()]TJ
/F7 1 Tf
(ve)Tj
2.3414 0 Td
(T)Tj
0.8277 0 Td
(cells)Tj
1.9219 0 Td
(towards)Tj
3.4016 0 Td
(Th17)Tj
2.313 0 Td
(cells)Tj
1.9162 0 Td
(is)Tj
-34.469 -1.2983 Td
(reduced.)Tj
3.6623 0 Td
(However,)Tj
4.0705 0 Td
(to)Tj
1.0205 0 Td
(date)Tj
1.8992 0 Td
(it)Tj
0.7767 0 Td
(is)Tj
0.8447 0 Td
(not)Tj
1.5647 0 Td
(known)Tj
2.999 0 Td
(whether)Tj
3.4696 0 Td
(Th17)Tj
2.3074 0 Td
(differentiation)Tj
5.9697 0 Td
(can)Tj
1.6214 0 Td
(be)Tj
1.1396 0 Td
(further)Tj
3.0217 0 Td
(reduced)Tj
-34.367 -1.3039 Td
(when)Tj
2.4037 0 Td
(both)Tj
2.058 0 Td
(IL-6)Tj
1.9275 0 Td
(and)Tj
1.7291 0 Td
(IL-21)Tj
2.3981 0 Td
(pathways)Tj
3.9345 0 Td
(are)Tj
1.4456 0 Td
(blocked.)Tj
3.5773 0 Td
(Therefore,)Tj
4.3937 0 Td
(the)Tj
1.4684 0 Td
(purpose)Tj
3.4469 0 Td
(of)Tj
1.0148 0 Td
(this)Tj
1.6724 0 Td
(study)Tj
2.3867 0 Td
(was)Tj
1.7008 0 Td
(to)Tj
-35.5575 -1.2983 Td
(determine)Tj
4.3199 0 Td
(whether)Tj
3.4809 0 Td
(IL-6/IL-21)Tj
4.4334 0 Td
(combinatorial)Tj
5.8507 0 Td
(pathway)Tj
3.5659 0 Td
(blockade)Tj
3.7871 0 Td
(has)Tj
1.542 0 Td
(additional)Tj
4.2803 0 Td
(inhibitory)Tj
-31.2602 -1.2983 Td
(effects)Tj
2.7269 0 Td
(on)Tj
1.2755 0 Td
(Th17)Tj
2.3074 0 Td
(differentiation,)Tj
6.2022 0 Td
(and)Tj
1.7291 0 Td
(more)Tj
2.3414 0 Td
(effectively)Tj
4.2123 0 Td
(reduces)Tj
3.2825 0 Td
(development)Tj
5.4084 0 Td
(of)Tj
1.0148 0 Td
(T)Tj
0.8278 0 Td
(cell-dependent)Tj
-31.3283 -1.3039 Td
(experimental)Tj
5.4594 0 Td
(arthritis.)Tj
3.6397 0 Td
(Firstly,)Tj
2.9707 0 Td
(we)Tj
1.3266 0 Td
(assessed)Tj
3.4753 0 Td
(the)Tj
1.4683 0 Td
(effects)Tj
2.7269 0 Td
(of)Tj
1.0148 0 Td
(complete)Tj
3.8778 0 Td
(IL-6/IL-21)Tj
4.4333 0 Td
(pathway)Tj
3.5717 0 Td
(inhibi-)Tj
-33.9645 -1.2982 Td
(tion)Tj
1.8425 0 Td
(on)Tj
1.2699 0 Td
(Th17)Tj
2.313 0 Td
(differentiation)Tj
/F13 1 Tf
5.9754 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()14()7()20()]TJ
/F7 1 Tf
(.)Tj
2.2734 0 Td
(Secondly,)Tj
4.0535 0 Td
(we)Tj
1.3266 0 Td
(used)Tj
2.058 0 Td
(IL-6)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 438.3496 425.8204 cm
BT
/F7 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(-/-)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 448.2708 421.3984 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(x)Tj
0.6803 0 Td
(IL-21R)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 483.137 425.8204 cm
BT
/F7 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(-/-)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 493.0015 421.3984 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(mice)Tj
2.1543 0 Td
(to)Tj
1.0261 0 Td
(study)Tj
2.3868 0 Td
(the)Tj
/F13 1 Tf
1.474 0 Td
[()12()]TJ
-36.3399 -1.2982 Td
[()-13()15()3()]TJ
/F7 1 Tf
1.8199 0 Td
(effects)Tj
2.7269 0 Td
(of)Tj
1.0148 0 Td
(cytokine)Tj
3.6396 0 Td
(pathway)Tj
3.566 0 Td
(blockade)Tj
3.7871 0 Td
(on)Tj
1.2755 0 Td
(Th17)Tj
2.3074 0 Td
(differentiation)Tj
5.9811 0 Td
(and)Tj
1.7291 0 Td
(development)Tj
5.4084 0 Td
(of)Tj
1.0148 0 Td
(experi-)Tj
-34.2706 -1.3039 Td
(mental)Tj
2.9877 0 Td
(arthritis.)Tj
3.6454 0 Td
(Finally,)Tj
3.1691 0 Td
(we)Tj
1.3266 0 Td
(investigated)Tj
4.9889 0 Td
(the)Tj
1.4684 0 Td
(therapeutic)Tj
4.7338 0 Td
(potential)Tj
3.7587 0 Td
(of)Tj
1.0148 0 Td
(our)Tj
1.6271 0 Td
(combined)Tj
4.2462 0 Td
(blocking)Tj
-32.9667 -1.2983 Td
(strategy)Tj
3.3279 0 Td
(by)Tj
1.1792 0 Td
(treating)Tj
3.3278 0 Td
(mice)Tj
2.1544 0 Td
(with)Tj
1.9955 0 Td
(collagen-induced)Tj
7.1093 0 Td
(arthritis)Tj
3.4186 0 Td
(\(CIA\))Tj
2.5851 0 Td
(with)Tj
1.9956 0 Td
(anti-IL-6R)Tj
4.4446 0 Td
(antibodies)Tj
4.3653 0 Td
(and)Tj
-35.9033 -1.2983 Td
(soluble)Tj
3.0388 0 Td
(\(s\)IL-21R.Fc.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 343.2188 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Materials)Tj
4.5071 0 Td
(and)Tj
1.989 0 Td
(methods)Tj
/F0 1 Tf
-6.4961 -1.5023 Td
(Mice)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 308.1826 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Wild)Tj
2.228 0 Td
(type)Tj
1.9105 0 Td
(\(WT\))Tj
2.4775 0 Td
(C57Bl6/J)Tj
3.7984 0 Td
(mice)Tj
2.1486 0 Td
(and)Tj
1.7348 0 Td
(DBA-1)Tj
3.0444 0 Td
(mice)Tj
2.1543 0 Td
(were)Tj
2.1203 0 Td
(purchased)Tj
4.337 0 Td
(from)Tj
2.2053 0 Td
(Janvier-Elevage)Tj
6.4176 0 Td
(\(Le)Tj
-34.5767 -1.2982 Td
(Genest)Tj
2.9876 0 Td
(Saint)Tj
2.2394 0 Td
(Isle,)Tj
1.8142 0 Td
(France\),)Tj
3.5092 0 Td
(and)Tj
1.7292 0 Td
(breeding)Tj
3.753 0 Td
(pairs)Tj
2.1657 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4626 0 Td
(IL-21R-deficient)Tj
6.8371 0 Td
(mice)Tj
2.1544 0 Td
(on)Tj
1.2699 0 Td
(a)Tj
0.6519 0 Td
(C57Bl6/J)Tj
3.7928 0 Td
(back-)Tj
-35.3818 -1.2983 Td
(ground)Tj
3.1691 0 Td
(were)Tj
2.1203 0 Td
(provided)Tj
3.8154 0 Td
(by)Tj
1.1792 0 Td
(Pfizer.)Tj
2.7722 0 Td
(Breeding)Tj
3.8268 0 Td
(pairs)Tj
2.1713 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(IL-6)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 432.3968 286.6393 cm
BT
/F12 1 Tf
1 TL
-0.0053 Tc
0 0 Td
[()]TJ
/F7 1 Tf
(/)Tj
/F12 1 Tf
[()]TJ
ET
Q
q
1 j
1 J
0 w
10 0 0 10 445.6062 282.2173 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(mice,)Tj
2.381 0 Td
(back-crossed)Tj
5.4028 0 Td
(eight)Tj
2.2054 0 Td
(times)Tj
-34.5484 -1.3039 Td
(with)Tj
1.9956 0 Td
(C57Bl6/J,)Tj
4.0195 0 Td
(were)Tj
2.126 0 Td
(a)Tj
0.652 0 Td
(kind)Tj
2.0579 0 Td
(gift)Tj
1.542 0 Td
(from)Tj
2.2054 0 Td
(Dr)Tj
1.3266 0 Td
(Manfred)Tj
3.7077 0 Td
(Kopf)Tj
2.2053 0 Td
(\(Basel,)Tj
2.8289 0 Td
(Switzerland\)[)Tj
0.83 0.64 0.02 0 k
(23)Tj
0 g
(].)Tj
7.1092 0 Td
(Animals)Tj
3.5773 0 Td
(were)Tj
-35.3534 -1.2982 Td
(used)Tj
2.058 0 Td
(between)Tj
3.5319 0 Td
(10)Tj
1.1679 0 Td
(and)Tj
1.7291 0 Td
(12)Tj
1.1735 0 Td
(weeks)Tj
2.6079 0 Td
(of)Tj
1.0148 0 Td
(age)Tj
1.542 0 Td
(and)Tj
1.7292 0 Td
(were)Tj
2.1259 0 Td
(housed)Tj
3.0954 0 Td
(in)Tj
1.0319 0 Td
(filter-top)Tj
3.7869 0 Td
(cages)Tj
2.3301 0 Td
(under)Tj
2.6192 0 Td
(specific)Tj
3.1918 0 Td
(patho-)Tj
-34.7355 -1.2983 Td
(gen-free)Tj
3.515 0 Td
(conditions.)Tj
4.6998 0 Td
(Microbiome)Tj
5.2044 0 Td
(synchronization)Tj
6.6954 0 Td
(was)Tj
1.7007 0 Td
(promoted)Tj
4.1895 0 Td
(by)Tj
1.1849 0 Td
(housing)Tj
3.4242 0 Td
(purchased)Tj
4.3313 0 Td
(WT)Tj
-34.9452 -1.3039 Td
(mice)Tj
2.1544 0 Td
(near)Tj
1.9955 0 Td
(the)Tj
1.4684 0 Td
(genetically)Tj
4.4503 0 Td
(modified)Tj
3.8495 0 Td
(mice)Tj
2.1543 0 Td
(for)Tj
1.3833 0 Td
(a)Tj
0.6576 0 Td
(period)Tj
2.8346 0 Td
(of)Tj
1.0148 0 Td
(at)Tj
0.9525 0 Td
(least)Tj
1.9784 0 Td
(one)Tj
1.7008 0 Td
(week,)Tj
2.4718 0 Td
(before)Tj
2.7439 0 Td
(initiating)Tj
-31.8101 -1.2983 Td
(experiments.)Tj
5.3632 0 Td
(A)Tj
0.9014 0 Td
(standard)Tj
3.7247 0 Td
(diet)Tj
1.7348 0 Td
(and)Tj
1.7347 0 Td
(water)Tj
2.4322 0 Td
(were)Tj
2.1203 0 Td
(provided)Tj
3.8154 0 Td
(ad)Tj
1.1848 0 Td
(libitum.)Tj
3.3732 0 Td
(Before)Tj
2.8176 0 Td
(being)Tj
2.4264 0 Td
(sacrificed)Tj
4.0082 0 Td
(by)Tj
-35.6369 -1.2982 Td
(cervical)Tj
3.2599 0 Td
(dislocation,)Tj
4.8358 0 Td
(mice)Tj
2.1543 0 Td
(were)Tj
2.1204 0 Td
(anesthetized)Tj
5.1646 0 Td
(using)Tj
2.3925 0 Td
(23%)Tj
2.4434 0 Td
(isoflurane.)Tj
4.4219 0 Td
(All)Tj
1.3947 0 Td
(animal)Tj
2.9707 0 Td
(procedures)Tj
-31.1582 -1.2983 Td
(were)Tj
2.1203 0 Td
(approved)Tj
3.9742 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.474 0 Td
(ethics)Tj
2.5171 0 Td
(committee)Tj
4.5014 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(Radboud)Tj
3.8721 0 Td
(University)Tj
4.4049 0 Td
(Nijmegen)Tj
4.1612 0 Td
(\(approval)Tj
4.0422 0 Td
(num-)Tj
-34.7298 -1.3039 Td
(bers)Tj
1.8822 0 Td
(2014045,)Tj
4.2917 0 Td
(2010002,)Tj
4.2916 0 Td
(and)Tj
1.7291 0 Td
(2012207\).)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 151.9937 cm
BT
/F6 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(In)Tj
1.0441 0 Td
(vitro)Tj
/F0 1 Tf
2.0882 0 Td
(stimulation)Tj
4.937 0 Td
(of)Tj
1.0488 0 Td
(CD4+)Tj
2.778 0 Td
(T)Tj
0.8315 0 Td
(cells)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 134.9858 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Na)Tj
/F12 1 Tf
[()]TJ
/F7 1 Tf
(ve)Tj
2.5228 0 Td
(murine)Tj
3.1804 0 Td
(T)Tj
0.8277 0 Td
(helper)Tj
2.7326 0 Td
(cells)Tj
1.9219 0 Td
(were)Tj
2.1203 0 Td
(negatively)Tj
4.2349 0 Td
(selected)Tj
3.3506 0 Td
(from)Tj
2.2053 0 Td
(spleen,)Tj
2.965 0 Td
(isolated)Tj
3.2825 0 Td
(from)Tj
2.2054 0 Td
(IL-21R)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 543.5149 139.4645 cm
BT
/F7 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(-/-)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 553.4362 134.9858 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(or)Tj
-35.3421 -1.2982 Td
(WT)Tj
1.7972 0 Td
(C57Bl6/J)Tj
3.7927 0 Td
(mice)Tj
2.1543 0 Td
(using)Tj
2.3924 0 Td
(a)Tj
0.652 0 Td
(mouse)Tj
2.8573 0 Td
(na)Tj
/F12 1 Tf
[()]TJ
/F7 1 Tf
(ve)Tj
2.3414 0 Td
(CD4)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 378.5952 126.4251 cm
BT
/F7 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(+)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 385.1716 122.0031 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(T)Tj
0.8277 0 Td
(Cell)Tj
1.8028 0 Td
(Isolation)Tj
3.7247 0 Td
(Kit)Tj
1.4627 0 Td
(\(Miltenyi)Tj
3.9571 0 Td
(Biotec,)Tj
2.9423 0 Td
(Bergisch)Tj
-33.233 -1.2982 Td
(Gladbach,)Tj
4.2576 0 Td
(Germany\).)Tj
4.5524 0 Td
(Na)Tj
/F12 1 Tf
[()]TJ
/F7 1 Tf
(ve)Tj
2.5285 0 Td
(CD4)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 332.1637 113.4425 cm
BT
/F7 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(+)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 338.6834 109.0204 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(T)Tj
0.8333 0 Td
(cells)Tj
1.9162 0 Td
(were)Tj
2.126 0 Td
(cultured)Tj
3.566 0 Td
(for)Tj
1.3833 0 Td
(four)Tj
1.9162 0 Td
(days)Tj
1.9956 0 Td
(in)Tj
1.0374 0 Td
(6-wells)Tj
3.0047 0 Td
(plates)Tj
2.5002 0 Td
(at)Tj
0.9524 0 Td
(37C,)Tj
-35.0982 -1.3039 Td
(5%)Tj
1.4513 0 Td
(CO)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 228.6425 94.337 cm
BT
/F7 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 232.1574 95.9811 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(,)Tj
0.4478 0 Td
(in)Tj
1.0375 0 Td
(RPMI-1640)Tj
4.8869 0 Td
(medium)Tj
3.6056 0 Td
(containing)Tj
4.5241 0 Td
(5%)Tj
1.457 0 Td
(fetal)Tj
1.9049 0 Td
(calf)Tj
1.6157 0 Td
(serum)Tj
2.7213 0 Td
(\(FCS\),)Tj
2.7949 0 Td
(50)Tj
/F12 1 Tf
1.1679 0 Td
[()]TJ
/F7 1 Tf
(m)Tj
/F11 1 Tf
1.5477 0 Td
()Tj
/F7 1 Tf
(-mercaptoetha-)Tj
-30.9257 -1.2982 Td
(nol,)Tj
1.7461 0 Td
(50)Tj
/F12 1 Tf
1.1735 0 Td
[()]TJ
/F7 1 Tf
(g/ml)Tj
2.5851 0 Td
(gentamycin,)Tj
5.1307 0 Td
(and)Tj
1.7291 0 Td
(1%)Tj
1.4514 0 Td
(pyruvate.)Tj
3.9288 0 Td
(The)Tj
1.7801 0 Td
(following)Tj
3.9798 0 Td
(Th17)Tj
2.3131 0 Td
(stimulation)Tj
4.7905 0 Td
(cocktail)Tj
3.3165 0 Td
(was)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 427.9748 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(IL-6/IL-21)Tj
4.4291 0 Td
(targeti)Tj
2.7213 0 Td
(ng)Tj
1.311 0 Td
(in)Tj
0.978 0 Td
(experiment)Tj
4.8615 0 Td
(al)Tj
0.985 0 Td
(arthritis)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.4748 0 Td
(DOI:10.137)Tj
5.0387 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.0171)Tj
3.5434 0 Td
(757)Tj
2.6362 0 Td
(February)Tj
4.1599 0 Td
(3,)Tj
1.0417 0 Td
(2017)Tj
37.8995 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(16)Tj
/F8 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(Competing)Tj
4.3795 0 Td
(Interests)Tj
3.3307 0 Td
(:)Tj
/F9 1 Tf
0.4819 0 Td
(The)Tj
1.5875 0 Td
(authors)Tj
3.0401 0 Td
(have)Tj
1.963 0 Td
(declared)Tj
-14.7827 -1.3748 Td
(that)Tj
1.6228 0 Td
(no)Tj
1.1693 0 Td
(competing)Tj
4.1599 0 Td
(interests)Tj
ET
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
BT
10.3394 82.7156 Td
(exist.)Tj
ET
Q
endstream
endobj
51 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 15 0 R/Annots 53 0 R/Contents 54 0 R/TrimBox[0 0 612 792]>>
endobj
52 0 obj
<>
endobj
55 0 obj
<>
endobj
56 0 obj
<>stream
%!PS-AdobeFont-1.0
11 dict begin
/FontName /TeX_CM_Maths_Italic def
/FontType 1 def
/FontBBox {-31 -239 1041 750} readonly def
/FontMatrix [0.001 0 0 0.001 0 0] readonly def
/PaintType 0 def
/FontInfo 8 dict dup begin
/FullName (TeX_CM_Maths_Italic) readonly def
/BaseFontName (TeX_CM_Maths_Italic) def
end def
/Encoding 256 array
0 1 255 {1 index exch /.notdef put} for
dup 0 /C0 put
dup 1 /C1 put
dup 2 /C2 put
dup 3 /C3 put
dup 4 /C4 put
dup 5 /C5 put
dup 6 /C6 put
dup 7 /C7 put
dup 8 /C8 put
dup 9 /C9 put
dup 10 /C10 put
dup 11 /C11 put
dup 12 /C12 put
dup 13 /C13 put
dup 14 /C14 put
dup 15 /C15 put
dup 16 /C16 put
dup 17 /C17 put
dup 18 /C18 put
dup 19 /C19 put
dup 20 /C20 put
dup 21 /C21 put
dup 22 /C22 put
dup 23 /C23 put
dup 24 /C24 put
dup 25 /C25 put
dup 26 /C26 put
dup 27 /C27 put
dup 28 /C28 put
dup 29 /C29 put
dup 30 /C30 put
dup 31 /C31 put
dup 32 /space put
dup 33 /exclam put
dup 34 /quotedbl put
dup 35 /numbersign put
dup 36 /dollar put
dup 37 /percent put
dup 38 /ampersand put
dup 39 /quoteright put
dup 40 /parenleft put
dup 41 /parenright put
dup 42 /asterisk put
dup 43 /plus put
dup 44 /comma put
dup 45 /hyphen put
dup 46 /period put
dup 47 /slash put
dup 48 /zero put
dup 49 /one put
dup 50 /two put
dup 51 /three put
dup 52 /four put
dup 53 /five put
dup 54 /six put
dup 55 /seven put
dup 56 /eight put
dup 57 /nine put
dup 58 /colon put
dup 59 /semicolon put
dup 60 /less put
dup 61 /equal put
dup 62 /greater put
dup 63 /question put
dup 64 /at put
dup 65 /A put
dup 66 /B put
dup 67 /C put
dup 68 /D put
dup 69 /E put
dup 70 /F put
dup 71 /G put
dup 72 /H put
dup 73 /I put
dup 74 /J put
dup 75 /K put
dup 76 /L put
dup 77 /M put
dup 78 /N put
dup 79 /O put
dup 80 /P put
dup 81 /Q put
dup 82 /R put
dup 83 /S put
dup 84 /T put
dup 85 /U put
dup 86 /V put
dup 87 /W put
dup 88 /X put
dup 89 /Y put
dup 90 /Z put
dup 91 /bracketleft put
dup 92 /backslash put
dup 93 /bracketright put
dup 94 /asciicircum put
dup 95 /underscore put
dup 96 /quoteleft put
dup 97 /a put
dup 98 /b put
dup 99 /c put
dup 100 /d put
dup 101 /e put
dup 102 /f put
dup 103 /g put
dup 104 /h put
dup 105 /i put
dup 106 /j put
dup 107 /k put
dup 108 /l put
dup 109 /m put
dup 110 /n put
dup 111 /o put
dup 112 /p put
dup 113 /q put
dup 114 /r put
dup 115 /s put
dup 116 /t put
dup 117 /u put
dup 118 /v put
dup 119 /w put
dup 120 /x put
dup 121 /y put
dup 122 /z put
dup 123 /braceleft put
dup 124 /bar put
dup 125 /braceright put
dup 126 /asciitilde put
dup 127 /Euro put
readonly def
currentdict end
currentfile eexec
M#1H5 J6o\&rtS(#v\0\V7Fe༙OYx5-cY9^%Y6
(efIOldN"wȰ;)UƽoFg/rvV$JS8_oc@
o9-eGJp}[Do]mN=4*{ܯq=eU^t6¤.vA2*Sr 2@Y0}Rcx,TX|ZP
;o<[1?
T<=qo:-62/]8~i wX?wJ`lLkI@EjYׅq5ڧHtvc6i 0M]YUN;M]ť0]z[{s1uO[6be#9k~d/YpMA.=뤎P\|W#?W$iz81ZL
Ңri^?WP]X A.@
z[
75y6k .U*3}hA\t&HW!Q
=+Г A 5